Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy
H Wu, L Zhang, Z Zhu, C Ding, S Chen, R Liu… - Drug Delivery, 2021 - Taylor & Francis
CD123 targeting molecules have been widely applied in acute myelocytic leukemia (AML)
therapeutics. Although antibodies have been more widely used as targeting molecules …
therapeutics. Although antibodies have been more widely used as targeting molecules …